Comorbidity and medication load in adult asthmatics

Scandinavian Journal of Primary Health Care

Volumn 23, Issue 2, 2005, Pages 88-94

  Ikäheimo, Pekka ^a   Hartikainen, Sirpa ^b,c   Tuuponen, Tuili ^a,d   Kiuttu, Jorma ^e   Klaukka, Timo ^e  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Municipal Hospitals of Kuopio   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e SOCIAL INSURANCE INSTITUTION   (Finland)

Author keywords

Asthma; Comorbidity; Medication; Polypharmacy

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; OPIATE; PARACETAMOL; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PRESCRIPTION; REIMBURSEMENT; SELF REPORT;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COMORBIDITY; DRUG INTERACTIONS; FAMILY PRACTICE; FEMALE; FINLAND; HUMANS; MALE; POLYPHARMACY; PRESCRIPTIONS, DRUG; QUESTIONNAIRES;

EID: 21344468599     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430510018473     Document Type: Article

References (22)

1. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy 1996;26(Suppl 1):1-24.
2. Ikäheimo P, Tuuponen T, Hartikainen S, Kiuttu J, Klaukka T. Achievements and shortcomings of Finnish asthma care. Scand J Public Health 2004;4:310-6.
3. Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute B12/2004. Helsinki; 2004.
4. Klaukka T, Mäkelä M, Sipilä J, Martikainen J. Multiuse of medicines in Finland. Med Care 1993;5:445-50.
5. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003;21:153-8.
6. Bergman RB, Viholm BE. Drug-related problems causing admission to medical clinic. Eur J Clin Pharmacol 1981;20:193-200.
7. Barr RG, Somers SC, Speizer FE, Camargo CA. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002;162:1761-8.
8. Ben-Noun L. Drug-related asthma. J Pharm Technol 1998;14:116-24.
9. Mannesse CK, Derkx FHM, de Ridder MAJ, Man in't Veld AJ, van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29:35-9.
10. Goldberg P. The asthmatic with concomitant medical problems. Immunol Allergy Clin North Am 2001;21:473-88, VI.
11. Classification of medicines (ATC) and defined daily doses (DDD) 2000. National Agency for Medicines, Helsinki; 2000 [in Finnish and Swedish].
12. Van Manen JG, Bindels PJE, Ijzermans CJ, et al. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287-93.
13. Heliövaara M, Aromaa A, Klaukka T, et al. Reliability and validity of interview data on chronic diseases. The Mini-Finland Health Survey. J Clin Epidemiol 1993;46:181-91.
14. Diette GB, Krishnan JA, Dominici F, Haponik E, Skinner EA, Steinwachs D, et al. Asthma in older patients - Factors associated with hospitalization. Arch Intern Med 2002;162:1123-32.
15. Bugiani M, Carosso A, Migliore E, et al. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy 2005;60:165-70.
16. Cusack BJ, Nielson CP, Vestal RE. Geriatric clinical pharmacology and therapeutics. In: Speight TM, Holford NHG, editors. Avery's Drug Treatment: A guide to the properties, choice, therapeutic use and economic value of drugs in disease management, 4th ed. Auckland: Adis International Limited; 1997. p. 173-223.
17. Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, et al. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions. Eur J Clin Pharmacol 2001;56:781-91.
18. McGavin JK, Goa KL, Jarvis B. Inhaled budesonide/formoterol combination. Drugs 2001;61:71-8.
19. Lunde H, Hedner T, Samuelsson O, Lotvall J, Andren L, Lindholm L, et al. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. BMJ 1994;308:18-21.
20. Blanc PD, Kuschner WG, Katz PP, Smith S, Yelin EH. Use of herbal products, coffee or black tea, and over-the-counter medications as self-treatment among adults with asthma. J Allergy Clin Immunol 1997;100(6 Pt 1):789-91.
21. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Can Med Assoc J 1996;154:1177-84.
22. Del Piccolo L, Saltini A, Zimmermann C. Which patients talk about stressful life events and social problems to the general practitioner? Psychol Med 1998;28:1289-99.